Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David H Munn

Showing results (121-130 of 143) with videos related to

Pageof 15
Sort By:
Nature Communications|March 22, 2019
ER stress-induced mediator C/EBP homologous protein thwarts effector T cell activity in tumors through T-bet repressionYu Cao, Jimena Trillo-Tinoco, Rosa A Sierra, et al.
Science Immunology|December 15, 2019
GCN2 drives macrophage and MDSC function and immunosuppression in the tumor microenvironmentMarie Jo Halaby, Kebria Hezaveh, Sara Lamorte, et al.
Cancer Cell|March 7, 2025
Lymph node macrophages drive immune tolerance and resistance to cancer therapy by induction of the immune-regulatory cytokine IL-33Sara Lamorte, Rene Quevedo, Robbie Jin, et al.
Blood|July 2, 2013
Inhibiting retinoic acid signaling ameliorates graft-versus-host disease by modifying T-cell differentiation and intestinal migrationKazutoshi Aoyama, Asim Saha, Jakub Tolar, et al.
Journal for Immunotherapy of Cancer|June 21, 2018
Phase Ia study of the indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor navoximod (GDC-0919) in patients with recurrent advanced solid tumorsAsha Nayak-Kapoor, Zhonglin Hao, Ramses Sadek, et al.
Blood|March 28, 2015
B7-H3 expression in donor T cells and host cells negatively regulates acute graft-versus-host disease lethalityRachelle G Veenstra, Ryan Flynn, Katharina Kreymborg, et al.
JCI Insight|October 4, 2019
Donor and host B7-H4 expression negatively regulates acute graft-versus-host disease lethalityAsim Saha, Patricia A Taylor, Christopher J Lees, et al.
Nature Immunology|May 16, 2018
Apoptotic cell-induced AhR activity is required for immunological tolerance and suppression of systemic lupus erythematosus in mice and humansRahul Shinde, Kebria Hezaveh, Marie Jo Halaby, et al.
Cancer Immunology Research|March 8, 2017
Promoter Methylation Modulates Indoleamine 2,3-Dioxygenase 1 Induction by Activated T Cells in Human Breast CancersSatish K Noonepalle, Franklin Gu, Eun-Joon Lee, et al.
Blood|May 14, 2014
Increased T follicular helper cells and germinal center B cells are required for cGVHD and bronchiolitis obliteransRyan Flynn, Jing Du, Rachelle G Veenstra, et al.
Pageof 15

Showing results (121-130 of 143) with videos related to

Sort By:
Pageof 15
Nature Communications|March 22, 2019
ER stress-induced mediator C/EBP homologous protein thwarts effector T cell activity in tumors through T-bet repressionYu Cao, Jimena Trillo-Tinoco, Rosa A Sierra, et al.
Science Immunology|December 15, 2019
GCN2 drives macrophage and MDSC function and immunosuppression in the tumor microenvironmentMarie Jo Halaby, Kebria Hezaveh, Sara Lamorte, et al.
Cancer Cell|March 7, 2025
Lymph node macrophages drive immune tolerance and resistance to cancer therapy by induction of the immune-regulatory cytokine IL-33Sara Lamorte, Rene Quevedo, Robbie Jin, et al.
Blood|July 2, 2013
Inhibiting retinoic acid signaling ameliorates graft-versus-host disease by modifying T-cell differentiation and intestinal migrationKazutoshi Aoyama, Asim Saha, Jakub Tolar, et al.
Journal for Immunotherapy of Cancer|June 21, 2018
Phase Ia study of the indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor navoximod (GDC-0919) in patients with recurrent advanced solid tumorsAsha Nayak-Kapoor, Zhonglin Hao, Ramses Sadek, et al.
Blood|March 28, 2015
B7-H3 expression in donor T cells and host cells negatively regulates acute graft-versus-host disease lethalityRachelle G Veenstra, Ryan Flynn, Katharina Kreymborg, et al.
JCI Insight|October 4, 2019
Donor and host B7-H4 expression negatively regulates acute graft-versus-host disease lethalityAsim Saha, Patricia A Taylor, Christopher J Lees, et al.
Nature Immunology|May 16, 2018
Apoptotic cell-induced AhR activity is required for immunological tolerance and suppression of systemic lupus erythematosus in mice and humansRahul Shinde, Kebria Hezaveh, Marie Jo Halaby, et al.
Cancer Immunology Research|March 8, 2017
Promoter Methylation Modulates Indoleamine 2,3-Dioxygenase 1 Induction by Activated T Cells in Human Breast CancersSatish K Noonepalle, Franklin Gu, Eun-Joon Lee, et al.
Blood|May 14, 2014
Increased T follicular helper cells and germinal center B cells are required for cGVHD and bronchiolitis obliteransRyan Flynn, Jing Du, Rachelle G Veenstra, et al.
Pageof 15